BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3511700)

  • 1. Effect of intraperitoneal insulin on solute kinetics in CAPD: insulin kinetics in CAPD.
    Rubin J; Reed V; Adair C; Bower J; Klein E
    Am J Med Sci; 1986 Feb; 291(2):81-7. PubMed ID: 3511700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transport kinetics of pseudouridine during hemodialysis and continuous ambulatory peritoneal dialysis.
    Struijk DG; Schoots AC; Koole LH; van der Reijden HJ; Koomen GC; Krediet RT; Arisz L
    J Lab Clin Med; 1991 Jul; 118(1):74-80. PubMed ID: 2066647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Indirect measurement of lymphatic absorption with inulin in continuous ambulatory peritoneal dialysis (CAPD) patients.
    Struijk DG; Krediet RT; Koomen GC; Boeschoten EW; vd Reijden HJ; Arisz L
    Perit Dial Int; 1990; 10(2):141-5. PubMed ID: 2085599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peritoneal fluid kinetics during CAPD measured with intraperitoneal dextran 70.
    Krediet RT; Struijk DG; Koomen GC; Arisz L
    ASAIO Trans; 1991; 37(4):662-7. PubMed ID: 1722690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraperitoneal insulin in uraemic diabetics undergoing continuous ambulatory peritoneal dialysis.
    Balducci A; Slama G; Rottembourg J; Baumelou A; Delage A
    Br Med J (Clin Res Ed); 1981 Oct; 283(6298):1021-3. PubMed ID: 6794746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations in the peritoneal transport of water and solutes during peritonitis in continuous ambulatory peritoneal dialysis patients.
    Krediet RT; Zuyderhoudt FM; Boeschoten EW; Arisz L
    Eur J Clin Invest; 1987 Feb; 17(1):43-52. PubMed ID: 3106050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of intraperitoneal administration of two different batches of albumin solutions on peritoneal solute transport in CAPD patients.
    Struijk DG; Bakker JC; Krediet RT; Koomen GC; Stekkinger P; Arisz L
    Nephrol Dial Transplant; 1991; 6(3):198-202. PubMed ID: 1866048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of the peritoneal mass transfer of parathormone in patients under continuous ambulatory peritoneal dialysis therapy.
    Rodríguez-Carmona A; Selgas R; Martínez ME; Ortí F; Miguel JL; Salinas M; Riñón C; Sánchez-Sicilia L
    Nephron; 1984; 37(1):21-4. PubMed ID: 6717700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dialysate to plasma solute concentration (D/P) versus peritoneal transport parameters in CAPD.
    Heimbürger O; Waniewski J; Werynski A; Park MS; Lindholm B
    Nephrol Dial Transplant; 1994; 9(1):47-59. PubMed ID: 8177476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in fluid and solute transport between diabetic and nondiabetic patients at the onset of CAPD.
    Serlie MJ; Struijk DG; de Blok K; Krediet RT
    Adv Perit Dial; 1997; 13():29-32. PubMed ID: 9360646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of peritoneal transport in rats by disrupting stagnant fluid films.
    Rubin J; Jones Q; Planch A; Lockard V; Bower J
    Am J Med Sci; 1988 Feb; 295(2):108-13. PubMed ID: 3344758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic subcapsular steatosis as a complication associated with intraperitoneal insulin treatment in diabetic peritoneal dialysis patients.
    Torun D; Oguzkurt L; Sezer S; Zumrutdal A; Singan M; Adam FU; Ozdemir FN; Haberal M
    Perit Dial Int; 2005; 25(6):596-600. PubMed ID: 16411528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simple assessment of the efficacy of peritoneal transport in continuous ambulatory peritoneal dialysis patients.
    Krediet RT; Boeschoten EW; Zuyderhoudt FM; Strackee J; Arisz L
    Blood Purif; 1986; 4(4):194-203. PubMed ID: 3790265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transfer of native insulin through the peritoneal membrane during CAPD in non-diabetic and diabetic patients.
    Ersoy FF; Karayalcin U; Karayalcin B; Sapan M; Bozcuk H; Süleymanlar G; Yakupoglu G
    Adv Perit Dial; 1995; 11():119-22. PubMed ID: 8534683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of peritoneal dialysis and the use of subcutaneous and intraperitoneal insulin on glucose metabolism and serum lipids in type 1 diabetic patients.
    Nevalainen P; Lahtela JT; Mustonen J; Pasternack A
    Nephrol Dial Transplant; 1997 Jan; 12(1):145-50. PubMed ID: 9027790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High peritoneal residual volume decreases the efficiency of peritoneal dialysis.
    Wang T; Cheng HH; Heimbürger O; Bergström J; Lindholm B
    Kidney Int; 1999 May; 55(5):2040-8. PubMed ID: 10231469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Icodextrin with nitroprusside increases ultrafiltration and peritoneal transport during long CAPD dwells.
    Douma CE; Hiralall JK; de Waart DR; Struijk DG; Krediet RT
    Kidney Int; 1998 Apr; 53(4):1014-21. PubMed ID: 9551412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Intraperitoneal insulin therapy combined with continuous ambulatory peritoneal dialysis (CAPD)].
    Nevalainen P; Lahtela J; Mustonen J; Pasternack A
    Duodecim; 1996; 112(2):89-94. PubMed ID: 10590611
    [No Abstract]   [Full Text] [Related]  

  • 19. Individualized dialysis for CAPD patients: a review of the experience at the University of Missouri.
    Twardowski ZJ
    Uremia Invest; 1984; 8(1):35-43. PubMed ID: 6495473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Day-to-day variability of fluid and solute transport in upright and recumbent positions during CAPD.
    Imholz AL; Koomen GC; Voorn WJ; Struijk DG; Arisz L; Krediet RT
    Nephrol Dial Transplant; 1998 Jan; 13(1):146-53. PubMed ID: 9481731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.